PD-L1 Dysregulation in COVID-19 Patients

The COVID-19 pandemic has reached direct and indirect medical and social consequences with a subset of patients who rapidly worsen and die from severe-critical manifestations. As a result, there is still an urgent need to identify prognostic biomarkers and effective therapeutic approaches. Severe-cr...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in immunology 2021-06, Vol.12, p.695242
Main Authors:	Sabbatino, Francesco, Conti, Valeria, Franci, Gianluigi, Sellitto, Carmine, Manzo, Valentina, Pagliano, Pasquale, De Bellis, Emanuela, Masullo, Alfonso, Salzano, Francesco Antonio, Caputo, Alessandro, Peluso, Ilaria, Zeppa, Pio, Scognamiglio, Giosuè, Greco, Giuseppe, Zannella, Carla, Ciccarelli, Michele, Cicala, Claudia, Vecchione, Carmine, Filippelli, Amelia, Pepe, Stefano
Format:	Article
Language:	English
Subjects:	adaptive immune response Apoptosis Biopsy Cancer CD4 antigen COVID-19 Epithelial cells Genomes Immune checkpoint immune checkpoint molecules Immune response Immunology Immunomodulation Infections Informed consent innate immune response Kinases Leukocytes (neutrophilic) Ligands Lymphocytes T Monocytes Pandemics Patients PD-1 protein PD-L1 PD-L1 protein Pneumonia Respiratory distress syndrome SARS-CoV-2 Serum levels Severe acute respiratory syndrome coronavirus 2 Statistical analysis
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!